086820.KQ Bio Solution Co.,Ltd. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
02:15
Feb 10
Feb 10
Cartilage regeneration pipeline targets osteoarthritis
Bio Solution is a cartilage regeneration play with two programs: CartiLife, a surgical cartilage therapy with fast growth and China market potential, and SpheroCure, an injectable non-surgical therapy aimed at the large osteoarthritis market. SpheroCure is very early in clinical development, but if it succeeds it could become a next-generation DMAD-class product, making the small-cap company a high-risk, high-potential watch.
MED
02:14
Feb 10
Feb 10
Bio Solution injectable cartilage.
Bio Solution's CartiLife surgical cartilage treatment has good data and China potential, while injectable SpheroCure could open a much larger non-surgical joint market. It is early-stage and a watchlist idea.
MED
About 086820.KQ Investor Commentary
Across the available history and selected sources, Buzzberg tracks 086820.KQ (Bio Solution Co.,Ltd.) across 1 sources: 0 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: Noh Young-rae, Noh Young.